Stay updated with breaking news from 09057220. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Federated Hermes Inc. increased its position in Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 28.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 79,490 shares of the medical research company’s stock after acquiring an additional 17,762 shares during the quarter. Federated Hermes Inc.’s […]
Kornitzer Capital Management Inc. KS lowered its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 9.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 36,647 shares of the medical research company’s stock after selling […]
Allspring Global Investments Holdings LLC increased its stake in shares of Bio-Rad Laboratories, Inc. (NYSE:BIO – Free Report) by 11.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 166,127 shares of the medical research company’s stock after purchasing an […]
Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the five brokerages that are currently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 1-year price target […]
Bio-Rad Laboratories (NYSE:BIO – Get Free Report) was downgraded by Citigroup from a “buy” rating to a “neutral” rating in a research note issued to investors on Wednesday, Marketbeat.com reports. They presently have a $365.00 target price on the medical research company’s stock, down from their previous target price of $400.00. Citigroup’s price target would […]